Pediatric Oncology New Treatments And Therapies | Pediatrics Conferences | Neonatology Conferences | Pediatrics Conferences 2025 | Neonatology Conference 2025 | Pediatrics Conference

Pediatric Oncology: New Treatments and Therapies

Home
Scientific Sessions
Pediatric Oncology: New Treatments and Therapies

Pediatric Oncology: New Treatments and Therapies

Pediatric oncology has seen significant advancements in recent years, offering new hope for children diagnosed with cancer. Innovations in treatment and therapy have improved survival rates and quality of life for young patients. One of the most promising developments is the use of targeted therapies, which aim to attack cancer cells while minimizing damage to healthy cells. These therapies focus on specific genetic mutations or molecular markers present in certain cancers, allowing for more personalized and effective treatments. For example, targeted therapies like tyrosine kinase inhibitors are used in the treatment of leukaemia and neuroblastoma. Immunotherapy has also revolutionized pediatric oncology. This treatment harnesses the body’s immune system to recognize and destroy cancer cells. Chimeric antigen receptor T-cell (CAR-T) therapy, which modifies a patient’s T-cells to target cancer cells, has shown remarkable success in treating pediatric leukaemia and lymphoma. Another exciting advancement is the use of precision medicine, which involves analysing a patient’s genetic makeup to identify the most effective treatment options. This approach allows for treatments tailored to the individual child’s cancer, leading to better outcomes and fewer side effects.

· Advancements in Immunotherapy for Pediatric Cancer
· Minimizing Side Effects of Pediatric Cancer Treatment
· Advances in Stem Cell Transplantation for Pediatric Cancer Patients
· Clinical Advances in Pediatric Neuroblastoma Treatment